Wendy Kimryn Rathmell
Overview
Explore the profile of Wendy Kimryn Rathmell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baechle J, Hanna D, Sekhar K, Rathmell J, Rathmell W, Baregamian N
Surgery
. 2021 Jul;
171(1):111-118.
PMID: 34261605
Background: Immunotherapeutic response failure of adrenocortical carcinomas highlights a need for novel strategies targeting immune cell populations in the tumor microenvironment to overcome tumor resistance and enhance therapeutic response. A...
2.
Chang E, Chong W, Kasoji S, Fielding J, Altun E, Mullin L, et al.
BMC Nephrol
. 2017 Aug;
18(1):266.
PMID: 28793871
Background: Patients with chronic kidney disease are at increased risk of cystic kidney disease that requires imaging monitoring in many cases. However, these same patients often have contraindications to contrast-enhanced...
3.
Chen J, Appelbaum D, Kocherginsky M, Cowey C, Rathmell W, Mcdermott D, et al.
Cancer Med
. 2013 Oct;
2(4):545-52.
PMID: 24156027
The mTOR (mammalian target of rapamycin) inhibitor, everolimus, affects tumor growth by targeting cellular metabolic proliferation pathways and delays renal cell carcinoma (RCC) progression. Preclinical evidence suggests that baseline elevated...
4.
Khandani A, Cowey C, Moore D, Gohil H, Rathmell W
Nucl Med Commun
. 2012 Jun;
33(9):967-73.
PMID: 22714005
Objective: The objective of this study was to collect preliminary data on the predictive value of pretherapy 18F-fluorodeoxyglucose positron emission tomography in primary renal cell carcinoma (RCC) patients undergoing neoadjuvant...